This article was originally published in The Gray Sheet
Executive SummarySales reps accounting for at least 50% of Sulzer's U.S. electrophysiology volume have accepted offers as of Oct. 28 to join Guidant's Cardiac Rhythm Management division, satisfying a "key condition" in the Sulzer purchase announced Sept. 21 ("The Gray Sheet" Sept. 28, p. 8). The price of the all-cash deal, pegged between $775 mil. and $850 mil, hinges on the number of reps who join Guidant by closing. Guidant will continue to offer employment to Sulzer reps not yet contacted
You may also be interested in...
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.